These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3729480)

  • 21. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemo-immunotherapy in advanced head and neck cancer.
    Recchia F; Sica G; De Filippis S; Rosselli M; Pompili P; Saggio G; Rea S
    Anticancer Res; 1999; 19(1B):773-7. PubMed ID: 10216492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 an 1999.
    Dunphy FR; Dunleavy TL; Harrison BR; Trinkaus KM; Kim HJ; Stack BC; Needles B; Boyd JH
    Cancer; 2001 Mar; 91(5):940-8. PubMed ID: 11251945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Wang HM; Wang CS; Chen JS; Chen IH; Liao CT; Chang TC
    Cancer; 2002 Jun; 94(11):2989-95. PubMed ID: 12115388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
    Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Palliative antineoplastic chemotherapy of patients with head and neck tumors].
    Kleemann D; Hingst V; Kramp B
    HNO; 1994 May; 42(5):275-9. PubMed ID: 7519592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemosensitivity testing of anticancer agents in head and neck tumors. I: Comparison between head and neck squamous cell cancers and thyroid cancers].
    Nakashima T; Tomita K; Kuratomi Y; Maehara Y; Kohnoe S
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):79-84. PubMed ID: 2297240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.
    Kish J; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh J; Weaver A; Al-Sarraf M
    Cancer Treat Rep; 1982 Mar; 66(3):471-4. PubMed ID: 7037180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An evaluation of multi-disciplinary treatment combined with intra-arterial chemotherapy of head and neck cancer].
    Matsuura S; Makino S; Satake B; Shimizu R; Sakaino K; Maehara Y; Nakamura Y; Miyama J
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1057-62. PubMed ID: 3932709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A critical consideration of the combined radiochemotherapy of head and neck tumors].
    Schlappack O; Springer B; Hainz A
    Strahlenther Onkol; 1994 Jan; 170(1):25-9. PubMed ID: 8303574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].
    Yamashita S; Hirao M; Tsujinaka T; Sawamura T; Nakamori S; Mishima H; Fujitani K; Ikenaga M; Kashiwazaki M; Masuda N
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1149-51. PubMed ID: 16121918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Choice of second-line chemotherapy for advanced breast cancer based on the chemosensitivity assay by in vitro colony assay].
    Inoue K; Mukaiyama T; Yamazaki H; Horikoshi N; Ogawa M; Kobayashi T; Aiba K; Kuraishi Y
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):356-61. PubMed ID: 3080968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro chemosensitivity testing of squamous cell carcinoma of the head and neck. A preliminary report.
    Elprana D; Schwachöfer J; Kuijpers W; van den Broek P; Wagener DJ
    Acta Otolaryngol; 1987; 103(5-6):529-36. PubMed ID: 2441566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multidisciplinary treatment of the head and neck cancer--FAR therapy and its modification and application].
    Komiyama S; Yanagita T; Kudo S; Kuwano N
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1731-6. PubMed ID: 3729478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.